Creative Biolabs - Produkty

Creative Biolabs is a global, research-based biotechnology company dedicated to the discovery and development of novel viral vaccines. Our researchers are working to improve the design of vaccines and develop novel approaches that can reduce cost and increase accessibility. Subunit-Vaccine-for-COVID-19 https://sars-cov-2.creative-biolabs.com/recombinant-subunit-vaccine-development-services-for-sars-cov2.htm

FK506 binding proteins (FKBPs), also known as tacrolimus, are a family of immunophilins ubiquitously widely existing in eukaryotic organisms such as humans, plants, animals and yeast. As a cytosolic FKBP, FK506-binding protein 12 (FKBP12, or FKBP1A) is the smallest member and the most researched one among the identified mammalian FKBPs, which was named for its molecular weight of 12 kDa. Early in 1989, FKBP12 was characterized as the target or receptor of the immunosuppressive drug FK506 and Rapamycin, of which both molecules were noncovalently bound to FKBP12 to inhibit its PPIase activity. FKBP12-targeting-PROTAC https://www.creative-biolabs.com/protac/ligand-design-for-FKBP12-targeting-protac.htm

Creative Biolabs is a contract development company specialized in phage engineering. With the support of our highly experienced genomic scientists and world-class instruments, Creative Biolabs drives forward and speeds up your phage engineering project. Our scientists are confident in offering the best services upon request. yeast-based-assembly-of-phage-genomes https://phagenbio.creative-biolabs.com/engineered-phages.htm

Equipped with world-leading technology platforms and professional scientific staff in phage screening and phage engineering, Creative Biolabs owns a wide range of natural phage sources from clinic and environment, and we have developed several effective strategies for phage engineering. Our scientists are pleased to share our cutting-edge technology in the discovery of phage targeting bacteria for the development of customized phage therapies. bacteriophage-vs-bacteria https://phagenbio.creative-biolabs.com/discovery-of-phage-targeting-bacteria.htm

oncolytic from Creative Biolabs. Creative Biolabs provides customized, standardized, reliable and high-quality oncolytic virus therapy development services for clients globally. oncolytics-drugs https://www.creative-biolabs.com/oncolytic-virus/oncolytic-virus-therapy-development.htm